111 Capital Invests $342,000 in HealthEquity, Inc. $HQY

111 Capital purchased a new position in HealthEquity, Inc. (NASDAQ:HQY) during the 2nd quarter, HoldingsChannel reports. The fund purchased 3,262 shares of the company’s stock, valued at approximately $342,000.

Several other institutional investors have also recently made changes to their positions in HQY. Invesco Ltd. increased its holdings in shares of HealthEquity by 50.6% in the first quarter. Invesco Ltd. now owns 2,446,198 shares of the company’s stock worth $216,171,000 after purchasing an additional 821,425 shares during the period. Nuveen LLC bought a new position in HealthEquity in the first quarter valued at $53,076,000. Price T Rowe Associates Inc. MD increased its stake in HealthEquity by 995.6% in the first quarter. Price T Rowe Associates Inc. MD now owns 639,345 shares of the company’s stock valued at $56,500,000 after acquiring an additional 580,988 shares during the last quarter. Westfield Capital Management Co. LP bought a new position in HealthEquity in the first quarter valued at $49,787,000. Finally, Ameriprise Financial Inc. increased its stake in HealthEquity by 148.1% in the first quarter. Ameriprise Financial Inc. now owns 669,939 shares of the company’s stock valued at $59,203,000 after acquiring an additional 399,897 shares during the last quarter. Institutional investors own 99.55% of the company’s stock.

HealthEquity Stock Performance

HealthEquity stock opened at $87.78 on Tuesday. The company has a current ratio of 4.23, a quick ratio of 4.23 and a debt-to-equity ratio of 0.47. The firm has a 50-day moving average of $91.99 and a 200-day moving average of $93.87. The firm has a market cap of $7.56 billion, a P/E ratio of 53.20, a P/E/G ratio of 1.27 and a beta of 0.47. HealthEquity, Inc. has a 1-year low of $74.07 and a 1-year high of $116.65.

Analysts Set New Price Targets

A number of research analysts recently commented on HQY shares. Raymond James Financial reissued a “strong-buy” rating and issued a $120.00 target price (up previously from $115.00) on shares of HealthEquity in a research note on Tuesday, July 8th. Weiss Ratings reissued a “hold (c+)” rating on shares of HealthEquity in a research note on Saturday, September 27th. Jefferies Financial Group increased their target price on HealthEquity from $130.00 to $134.00 and gave the company a “buy” rating in a research note on Wednesday, September 3rd. Barrington Research reissued an “outperform” rating and issued a $125.00 target price on shares of HealthEquity in a research note on Friday, August 29th. Finally, JPMorgan Chase & Co. upped their price target on shares of HealthEquity from $125.00 to $126.00 and gave the company an “overweight” rating in a research report on Wednesday, September 3rd. One investment analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and two have given a Hold rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $119.77.

Insider Buying and Selling at HealthEquity

In other news, EVP Delano Ladd sold 6,000 shares of the stock in a transaction dated Friday, September 19th. The shares were sold at an average price of $94.11, for a total transaction of $564,660.00. Following the completion of the sale, the executive vice president directly owned 79,456 shares in the company, valued at approximately $7,477,604.16. This represents a 7.02% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 1.50% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.